{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:44:55Z","timestamp":1793213095105,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To report patients with systemic lymphoma and cytomegalovirus (CMV)\u00a0retinitis, treated with a combination of oral and intravitreal antiviral agents on an outpatient basis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective cases series. Information was gathered from the database of the Uveitis clinics at Moorfields Eye Hospital, United Kingdom from December 2014 to December 2018. The inclusion criteria comprised the diagnosis of systemic lymphoma, associated with a diagnosis of CMV\u00a0retinitis. Exclusion criteria were alternative ocular diagnosis, human immunodeficiency virus (HIV), primary intraocular lymphoma, or other causes of immunosuppression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All seven subjects had been under oncologist care for systemic lymphoma. CMV\u00a0retinitis presented with a median of 61 months after the systemic lymphoma diagnosis. Five patients underwent a vitreous biopsy, and four of them returned PCR positive for CMV and the fifth patient had PCR positive in a blood sample. All patients were treated with oral Valganciclovir, with an induction dose of 900\u2009mg every 12\u2009h for up to 3 weeks until disease resolution and a maintenance dose thereafter. All but one received additional intravitreal Foscarnet injections, with a dose of 2.4\u2009mg \/0.1\u2009ml.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The management of patients with systemic lymphoma and CMV retinitis with oral and intravitreal antiviral agents, resulted in effective disease control.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41433-022-02267-0","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T08:02:48Z","timestamp":1664784168000},"page":"1895-1903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Successful treatment of cytomegalovirus retinitis with oral\/intravitreal antivirals in HIV-negative patients with lymphoma"],"prefix":"10.1038","volume":"37","author":[{"given":"Anastasia","family":"Tasiopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhian A.","family":"Urzua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"2267_CR1","first-page":"237","volume":"26","author":"A Carmichael","year":"2012","unstructured":"Carmichael A. Cytomegalovirus and the eye. Eye Lond Engl. 2012;26:237\u2013321.","journal-title":"Eye Lond Engl"},{"key":"2267_CR2","doi-asserted-by":"publisher","first-page":"e0200267","DOI":"10.1371\/journal.pone.0200267","volume":"13","author":"R Lachmann","year":"2018","unstructured":"Lachmann R, Loenenbach A, Waterboer T, Brenner N, Pawlita M, Michel A, et al. Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS One. 2018;13:e0200267.","journal-title":"PLoS One"},{"key":"2267_CR3","doi-asserted-by":"publisher","first-page":"e2034","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.","journal-title":"Rev Med Virol"},{"key":"2267_CR4","doi-asserted-by":"publisher","first-page":"e13035","DOI":"10.1111\/tid.13035","volume":"21","author":"G Ono","year":"2019","unstructured":"Ono G, Medina Pestana JO, Aranha Camargo LF. Late cytomegalovirus (CMV) infections after kidney transplantation under the preemptive strategy: Risk factors and clinical aspects. Transpl Infect Dis. 2019;21:e13035.","journal-title":"Transpl Infect Dis."},{"key":"2267_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/jop.2016.0140","volume":"33","author":"AD Port","year":"2017","unstructured":"Port AD, Orlin A, Kiss S, Patel S, D\u2019Amico DJ, Gupta MP. Cytomegalovirus Retinitis: A Review. J Ocul Pharm Ther. 2017;33:224\u201334.","journal-title":"J Ocul Pharm Ther"},{"key":"2267_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-021-00257-z","volume":"11","author":"S Reddy","year":"2021","unstructured":"Reddy S, Tyagi M, Behera S, Pappuru RR, Dave VP, Basu S, et al. Cytomegalovirus retinitis in patients of non-Hodgkin\u2019s lymphoma: clinical presentations and outcomes. J Ophthalmic Inflamm Infect. 2021;11:26.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2267_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hon.2453","volume":"36","author":"F Marchesi","year":"2018","unstructured":"Marchesi F, Pimpinelli F, Ensoli F, Mengarelli A. Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematol Oncol. 2018;36:381\u201391.","journal-title":"Hematol Oncol"},{"key":"2267_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jamaophthalmol.2013.2860","volume":"131","author":"K Pathanapitoon","year":"2013","unstructured":"Pathanapitoon K, Tesavibul N, Choopong P, Boonsopon S, Kongyai N, Ausayakhun S, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013;131:638\u201345.","journal-title":"JAMA Ophthalmol"},{"key":"2267_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/microorganisms8010055","volume":"8","author":"M Munro","year":"2019","unstructured":"Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019;8:55.","journal-title":"Microorganisms."},{"key":"2267_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00006982-199616040-00008","volume":"16","author":"MA Nasir","year":"1996","unstructured":"Nasir MA, Jaffe GJ. Cytomegalovirus retinitis associated with Hodgkin\u2019s disease. Retina. 1996;16:324\u20137.","journal-title":"Retina"},{"key":"2267_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/09273948.2013.786095","volume":"21","author":"A Radwan","year":"2013","unstructured":"Radwan A, Metzinger JL, Hinkle DM, Foster CS. Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocul Immunol Inflamm. 2013;21:324\u20138.","journal-title":"Ocul Immunol Inflamm"},{"key":"2267_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1869-5760-3-17","volume":"3","author":"JL Davis","year":"2013","unstructured":"Davis JL, Haft P, Hartley K. Retinal arteriolar occlusions due to cytomegalovirus retinitis in elderly patients without HIV. J Ophthalmic Inflamm Infect. 2013;3:17.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2267_CR13","doi-asserted-by":"publisher","first-page":"e761","DOI":"10.1111\/aos.13553","volume":"96","author":"Y Shapira","year":"2018","unstructured":"Shapira Y, Mimouni M, Vishnevskia-Dai V. Cytomegalovirus retinitis in HIV negative patients\u2014associated conditions, clinical presentation, diagnostic methods and treatment strategy. Acta Ophthalmol. 2018;96:e761\u20137.","journal-title":"Acta Ophthalmol"},{"key":"2267_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa011759","volume":"346","author":"DF Martin","year":"2002","unstructured":"Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, et al. Valganciclovir Study Group. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N. Engl J Med. 2002;346:1119\u201326.","journal-title":"N. Engl J Med"},{"key":"2267_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajo.2021.03.051","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group.","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Cytomegalovirus Retinitis. Am J Ophthalmol. 2021;228:245\u201354.","journal-title":"Am J Ophthalmol"},{"key":"2267_CR16","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","volume":"111","author":"KD Rosenberg","year":"2004","unstructured":"Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299\u2013306.","journal-title":"Ophthalmology"},{"key":"2267_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0002-9394(14)72899-5","volume":"118","author":"RS Moorthy","year":"1994","unstructured":"Moorthy RS, Rajeev B, Smith RE, Rao NA. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1994;118:197\u2013204.","journal-title":"Am J Ophthalmol"},{"key":"2267_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"2267_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2174\/187152611797636703","volume":"11","author":"SA Ross","year":"2011","unstructured":"Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11:466\u201374.","journal-title":"Infect Disord Drug Targets"},{"key":"2267_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/09273948.2019.1604003","volume":"28","author":"M Ho","year":"2020","unstructured":"Ho M, Invernizzi A, Zagora S, Tsui J, Oldani M, Lui G, et al. Presenting Features, Treatment and Clinical Outcomes of Cytomegalovirus Retinitis: Non-HIV Patients Vs HIV Patients. Ocul Immunol Inflamm. 2020;28:651\u20138.","journal-title":"Ocul Immunol Inflamm"},{"key":"2267_CR21","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1097\/IAE.0b013e318285f486","volume":"33","author":"EW Schneider","year":"2013","unstructured":"Schneider EW, Elner SG, van Kuijk FJ, Goldberg N, Lieberman RM, Eliott D, et al. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina. 2013;33:1791\u20139.","journal-title":"Retina."},{"key":"2267_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.joms.2006.01.019","volume":"64","author":"Y Myoken","year":"2006","unstructured":"Myoken Y, Sugata T, Fujita Y, Fujihara M, Iwato K, Murayama SY, et al. Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report. J Oral Maxillofac Surg. 2006;64:860\u20133.","journal-title":"J Oral Maxillofac Surg"},{"key":"2267_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1399-3062.2007.00241.x","volume":"10","author":"AJ Eid","year":"2008","unstructured":"Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008;10:13\u20138.","journal-title":"Transpl Infect Dis"},{"key":"2267_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/10428194.2018.1508666","volume":"60","author":"MV Dioverti","year":"2019","unstructured":"Dioverti MV, Parikh SA, Osmon DR, Habermann TM, Tande AJ. Cryptococcus neoformans infections in patients with lymphoproliferative neoplasms. Leuk Lymphoma. 2019;60:920\u20136.","journal-title":"Leuk Lymphoma"},{"key":"2267_CR25","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/bjophthalmol-2018-312191","volume":"102","author":"S Ausayakhun","year":"2018","unstructured":"Ausayakhun S, Yen M, Jirawison C, Ausayakhun S, Khunsongkiet P, Leenasirimakul P, et al. Visual acuity outcomes in cytomegalovirus retinitis: early versus late diagnosis. Br J Ophthalmol. 2018;102:1607\u201310.","journal-title":"Br J Ophthalmol"},{"key":"2267_CR26","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1097\/MPH.0b013e31827078ad","volume":"35","author":"R Singh","year":"2013","unstructured":"Singh R, Singh R, Trehan A, Jain R, Bhalekar S. Cytomegalovirus Retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone. J Pediatr Hematol Oncol. 2013;35:e118\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2267_CR27","first-page":"111","volume":"4","author":"AJ Patil","year":"2010","unstructured":"Patil AJ, Sharma A, Kenney MC, Kuppermann BD. Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients. Clin Ophthalmol. 2010;4:111\u20139.","journal-title":"Clin Ophthalmol"},{"key":"2267_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/OPTH.S6700","volume":"4","author":"MW Stewart","year":"2010","unstructured":"Stewart MW. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010;4:285\u201399.","journal-title":"Clin Ophthalmol"},{"key":"2267_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05579-2","volume":"20","author":"J Murray","year":"2020","unstructured":"Murray J, Hilbig A, Soe TT, Ei WLSS, Soe KP, Ciglenecki I. Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data. BMC Infect Dis. 2020;20:842.","journal-title":"BMC Infect Dis"},{"key":"2267_CR30","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00417-013-2368-6","volume":"251","author":"H Miao","year":"2013","unstructured":"Miao H, Tao Y, Jiang YR, Li XX. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation. Graefes Arch Clin Exp Ophthalmol. 2013;251:1829\u201333.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2267_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ajo.2016.03.015","volume":"165","author":"LP Iu","year":"2016","unstructured":"Iu LP, Fan MC, Lau JK, Chan TS, Kwong YL, Wong IY. Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis. Am J Ophthalmol. 2016;165:145\u201353.","journal-title":"Am J Ophthalmol"},{"key":"2267_CR32","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00417-014-2587-5","volume":"252","author":"A Agarwal","year":"2014","unstructured":"Agarwal A, Kumari N, Trehan A, Khadwal A, Dogra MR, Gupta V, et al. Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection. Graefes Arch Clin Exp Ophthalmol. 2014;252:1393\u2013401.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2267_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000517521","volume":"244","author":"MWM Wintergerst","year":"2021","unstructured":"Wintergerst MWM, Liu X, Terheyden JH, Pohlmann D, Li JQ, Montesano G, et al. Structural Endpoints and Outcome Measures in Uveitis. Ophthalmologica. 2021;244:465\u201379.","journal-title":"Ophthalmologica."},{"key":"2267_CR34","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep.2009;58:1\u2013207.","journal-title":"MMWR Recomm Rep."},{"key":"2267_CR35","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ophtha.2015.02.033","volume":"122","author":"DA Jabs","year":"2015","unstructured":"Jabs DA, Ahuja A, Van Natta ML, Lyon AT, Yeh S, Danis R. Studies of the Ocular Complications of AIDS Research Group. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort. Ophthalmology. 2015;122:1452\u201363.","journal-title":"Ophthalmology."},{"key":"2267_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1086\/432012","volume":"192","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Martin BK, Forman MS, Ricks MO. Cytomegalovirus Retinitis and Viral Resistance Research Group. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. J Infect Dis. 2005;192:640\u20139.","journal-title":"J Infect Dis"},{"key":"2267_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0161-6420(96)30548-4","volume":"103","author":"WR Freeman","year":"1996","unstructured":"Freeman WR. New developments in the treatment of CMV retinitis. Ophthalmology. 1996;103:999\u20131000.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02267-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02267-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02267-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T09:06:08Z","timestamp":1686906368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02267-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2267"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02267-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"14 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}